Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis

YQ Zhang, SL Zou, H Zhao, MM Zhang… - The American Journal of …, 2018 - Elsevier
Background The goal of this study was to investigate whether ceftriaxone combination
therapy is associated with better clinical outcomes than respiratory fluoroquinolone …

Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis

YQ Zhang, SL Zou, H Zhao… - … American journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The goal of this study was to investigate whether ceftriaxone combination
therapy is associated with better clinical outcomes than respiratory fluoroquinolone …

[PDF][PDF] Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis

YQ Zhang, SL Zou, H Zhao, MM Zhang, CL Han - 2018 - e-tarjome.com
Ying-Qi Zhang, MD a,⁎, Shui-Lan Zou, MD b, Hua Zhao, MD a, Ming-Ming Zhang, MD a, Cai-
Li Han, MD aa Department of Emergency Medicine, The First Hospital of Hebei Medical …

Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis.

YQ Zhang, SL Zou, H Zhao, MM Zhang… - The American Journal of …, 2018 - europepmc.org
BACKGROUND: The goal of this study was to investigate whether ceftriaxone combination
therapy is associated with better clinical outcomes than respiratory fluoroquinolone …